Skip to main content
SLU publication database (SLUpub)

Abstract

After comparing the morbidity patterns of COVID-19 infections, variations of oxytocin levels and some properties of the neurohormone oxytocin, the authors put forward their hypothesis that oxytocin might constitute a safe, inexpensive and readily available treatment for this disease.

Keywords

COVID-19; pandemic; treatment; oxytocin; immune system; inflammation

Published in

Clinical Neuropsychiatry
2020, volume: 17, number: 3, pages: 192-195

SLU Authors

Global goals (SDG)

SDG3 Good health and well-being

UKÄ Subject classification

Pharmacology and Toxicology

Publication identifier

  • DOI: https://doi.org/10.36131/CNEPUB20201703

Permanent link to this page (URI)

https://res.slu.se/id/publ/106969